CBIO
Crescent Biopharma, Inc.Closed12.91−1.55 −10.72%USD
NasdaqCM · as of Oct 13, 16:00 ET · 15m delayAfter hours 12.91 0.00%
Open
14.46
Prev close
14.46
Day range
12.8514.67
52-week range
8.7227.41
Volume
197.11K0.49×
Mkt cap
479.57M
P/E ttm
—
Fwd P/E
-4.91
EPS ttm
-7.63
Div yield
0.00%
Earnings
—
From 52w high
−52.90%
CBIO earnings and estimates
CBIO Next Report
Yahoo Finance · Nasdaq
No upcoming report date is published for CBIO.
EPS: Actual vs Estimate
Price Reaction
close before → close after the report
Recent Reports
| Quarter ending | Reported | EPS | Estimate | Surprise | Revenue | Next session | Five sessions |
|---|---|---|---|---|---|---|---|
| Jun '26 | Jul 30, 2026 BMO | −0.62 | −0.64 | +2.83% | $0 | +1.7% | +6.8% |
| Mar '26 | Apr 29, 2026 AMC | −0.70 | −0.79 | +11.02% | $0 | +6.8% | −13.8% |
| Dec '25 | Feb 26, 2026 BMO | −4.92 | −2.82 | −74.47% | $0 | −1.1% | −8.0% |
| Sep '25 | Nov 6, 2025 BMO | −1.37 | −1.39 | +1.26% | $0 | +5.4% | +5.0% |
Consensus Estimates and Revisions
| Period | EPS | Low · range · high | Growth | Revenue | Growth | 30d ago | 90d ago | Up / down (30d) |
|---|---|---|---|---|---|---|---|---|
| Current quarter Sep 2026 | −0.57 | −0.62−0.53 | +58.3% | $357.14K | 0.0% | −0.66 +14.1% | −0.66 +14.1% | 1 / 0 |
| Next quarter Dec 2026 | −0.61 | −0.63−0.57 | +87.7% | $357.14K | 0.0% | −0.73 +17.3% | −0.73 +17.3% | 1 / 0 |
| Current year Dec 2026 | −2.35 | −2.36−2.35 | +81.6% | $1.73M | 0.0% | −2.62 +10.2% | −2.62 +10.2% | 1 / 0 |
| Next year Dec 2027 | −2.63 | −3.27−1.98 | −11.8% | $4.79M | +177.4% | −2.94 +10.6% | −2.94 +10.6% | 0 / 1 |
The change columns show how the consensus has moved since then; steady upward revisions often precede beats. Ranges place the consensus between the lowest and highest analyst estimate.
Forward EPS Forecasts
Nasdaq · Zacks consensus
Quarterly
| Fiscal period | Consensus | Low · range · high | Analysts | Up / down (4w) |
|---|---|---|---|---|
| Sep 2026 | −0.72 | −0.85−0.64 | 5 | 0 / 0 |
| Dec 2026 | −0.75 | −0.86−0.65 | 5 | 0 / 0 |
| Mar 2027 | −0.86 | −0.99−0.74 | 3 | 0 / 0 |
| Jun 2027 | −0.91 | −1.08−0.81 | 3 | 0 / 0 |
| Sep 2027 | −1.05 | −1.16−0.86 | 3 | 0 / 0 |
Fiscal years
| Fiscal period | Consensus | Low · range · high | Analysts | Up / down (4w) |
|---|---|---|---|---|
| Dec 2026 | −2.93 | −3.30−2.77 | 6 | 0 / 0 |
| Dec 2027 | −3.17 | −4.60−2.24 | 6 | 0 / 0 |
| Dec 2028 | −3.65 | −4.32−2.92 | 3 | 0 / 0 |
| Dec 2029 | −3.91 | −4.66−3.27 | 3 | 0 / 0 |
Reactions run from the last close before a report to the first close after it (an after-the-close report is measured to the next day's close). The implied move is the at-the-money straddle for the first expiry after the report, the same rule as the bot's lgf emove.